EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Facilitators and Barriers to Uptake of Genetic and Cascade Testing in Familial Hypercholesterolemia: a Systematic Review

Chaitanyasre Lenin, Phoebe X H Lim, Ashna Nastar, Tavintharan Subramaniam, Sharon Pek, Magdalena Daccord, Elsie Evans, Emma Print, Frederick H F Chan, Konstadina Griva

International Journal of Behavioral Medicine · 2026-02 · 33 (1) · 69-82

DOI: 10.1007/s12529-025-10357-y ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Behavioral Medicine, online erschienen am 08.04.2025. Verfasst von Chaitanyasre Lenin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Precision Health Research, Singapore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Familial hypercholesterolemia (FH) is an underdiagnosed autosomal dominant genetic disorder that confers high but preventable risk for premature adverse cardiovascular events. Timely diagnosis is limited by low uptake of genetic testing (GT) and cascade testing (CT). This systematic review identifies barriers and facilitators for uptake of GT and CT in FH.

Method

Following PRISMA guidelines, seven databases were searched for studies on GT/CT in FH. Data reporting standards for qualitative studies were evaluated with COREQ and thematic synthesis was conducted. Of the 387 studies identified, 15 were included (qualitative N = 9, quantitative N = 6). These involved 272,954 respondents (qualitative n = 243, quantitative n = 272,711). COREQ scores ranged from 11 to 21 out of 32.

Results

Synthesis of qualitative data indicated family history of illness, being well informed, and value of GT as key facilitators of GT. Financial concerns, suboptimal clinical care, and no/low value of GT were identified as barriers. Facilitators of CT included responsibility to family, healthcare providers’ support for CT, and gains of CT, while barriers included disconnect from family, emotional costs, and no value knowing FH status. Quantitative studies reflect emotional distress avoidance, limited opportunity for family disclosure to invite, lack of knowledge, low communication efficacy, and difficulties accessing testing services as predictors impacting CT.

Conclusion

Beyond knowledge, perceptions about testing—especially perceived value of testing—emerged to be significantly affecting decisions for GT/CT. Disconnect from family is a maior predictor in CT, reducing the likelihood of probands extending an invitation to their family in support of CT. Future interventions should address barriers and facilitators at interpersonal, clinical and systemic levels to improve FH GT/CT uptake. Additionally, further research in diverse cultural contexts is required to bridge gaps in GT/CT services. Interventions should especially prioritize risk perception education and the development of health communication tools to supplement strong clinical guidance, driving a more patient-centered approach in decisions relating to GT/CT.

Schlagwörter

Stichwörter der Autor:innen

BarriersCardiovascular diseaseCascade testingFHFacilitatorsGenetic testingPrecision medicinePublic health

Autor:innen und Institutionen

  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Division of Endocrinology, Alexandra Hospital, Singapore, Singapore.
  • Diabetes Centre Admiralty Medical Centre, Division of Endocrinology, Department of Medicine, Khoo Teck Puat Hospital, Singapore, Singapore.
  • Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore.
  • FH Europe Foundation, Amsterdam, The Netherlands.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Level 18, Clinical Sciences Building, 11 Mandalay Road, Singapore, 308232, Singapore. konstadina.griva@ntu.edu.sg.

Förderung

  • Precision Health Research, Singapore

Zitieren

APA

Lenin, C., Lim, P. X. H., Nastar, A., Subramaniam, T., Pek, S., Daccord, M., Evans, E., Print, E., Chan, F. H. F., & Griva, K. (2026). Facilitators and Barriers to Uptake of Genetic and Cascade Testing in Familial Hypercholesterolemia: a Systematic Review. International Journal of Behavioral Medicine, 33(1), 69-82. https://doi.org/10.1007/s12529-025-10357-y

Vancouver

Lenin C, Lim PXH, Nastar A, Subramaniam T, Pek S, Daccord M, et al. Facilitators and Barriers to Uptake of Genetic and Cascade Testing in Familial Hypercholesterolemia: a Systematic Review. International Journal of Behavioral Medicine. 2026;33(1):69-82. doi:10.1007/s12529-025-10357-y

BibTeX
@article{Lenin2026,
  author = {Lenin, Chaitanyasre and Lim, Phoebe X H and Nastar, Ashna and Subramaniam, Tavintharan and Pek, Sharon and Daccord, Magdalena and Evans, Elsie and Print, Emma and Chan, Frederick H F and Griva, Konstadina},
  title = {Facilitators and Barriers to Uptake of Genetic and Cascade Testing in Familial Hypercholesterolemia: a Systematic Review},
  journal = {International Journal of Behavioral Medicine},
  year = {2026},
  volume = {33},
  number = {1},
  pages = {69--82},
  doi = {10.1007/s12529-025-10357-y}
}
Kostenlos starten →